These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Quality of life and health status in interstitial lung diseases. De Vries J; Drent M Curr Opin Pulm Med; 2006 Sep; 12(5):354-8. PubMed ID: 16926651 [TBL] [Abstract][Full Text] [Related]
4. Clinical utility of measures of breathlessness. Cullen DL; Rodak B Respir Care; 2002 Sep; 47(9):986-93. PubMed ID: 12188932 [TBL] [Abstract][Full Text] [Related]
5. Pathophysiological mechanisms of exertional breathlessness in chronic obstructive pulmonary disease and interstitial lung disease. Jensen D; Schaeffer MR; Guenette JA Curr Opin Support Palliat Care; 2018 Sep; 12(3):237-245. PubMed ID: 30074922 [TBL] [Abstract][Full Text] [Related]
6. Dyspnea and quality of life in patients with pulmonary fibrosis after six weeks of respiratory rehabilitation. Jastrzebski D; Gumola A; Gawlik R; Kozielski J J Physiol Pharmacol; 2006 Sep; 57 Suppl 4():139-48. PubMed ID: 17072040 [TBL] [Abstract][Full Text] [Related]
8. Pulmonary rehabilitation for dyspnea in the palliative-care setting. Sachs S; Weinberg RL Curr Opin Support Palliat Care; 2009 Jun; 3(2):112-9. PubMed ID: 19381095 [TBL] [Abstract][Full Text] [Related]
9. Rehabilitation in non-COPD: mechanisms of exercise limitation and pulmonary rehabilitation for patients with pulmonary fibrosis/restrictive lung disease. Markovitz GH; Cooper CB Chron Respir Dis; 2010; 7(1):47-60. PubMed ID: 19880656 [TBL] [Abstract][Full Text] [Related]
10. [Functional capacity (dyspnea) and quality of life in patients with chronic obstructive lung disease (COPD): instruments of assessment and methodological aspects]. Hütter BO; Würtemberger G Pneumologie; 1999 Mar; 53(3):133-42. PubMed ID: 10226475 [TBL] [Abstract][Full Text] [Related]
11. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study. Khanna D; Clements PJ; Furst DE; Chon Y; Elashoff R; Roth MD; Sterz MG; Chung J; FitzGerald JD; Seibold JR; Varga J; Theodore A; Wigley FM; Silver RM; Steen VD; Mayes MD; Connolly MK; Fessler BJ; Rothfield NF; Mubarak K; Molitor J; Tashkin DP; Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967 [TBL] [Abstract][Full Text] [Related]
12. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma. Garin MC; Highland KB; Silver RM; Strange C J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563 [TBL] [Abstract][Full Text] [Related]
13. Role of pulmonary rehabilitation in the management of patients with lung cancer. Shannon VR Curr Opin Pulm Med; 2010 Jul; 16(4):334-9. PubMed ID: 20531082 [TBL] [Abstract][Full Text] [Related]
14. Palliative care for people with non-malignant lung disease: summary of current evidence and future direction. Boland J; Martin J; Wells AU; Ross JR Palliat Med; 2013 Oct; 27(9):811-6. PubMed ID: 23838376 [TBL] [Abstract][Full Text] [Related]
15. Lung volume reduction surgery for the management of refractory dyspnea in chronic obstructive pulmonary disease. Shah AA; D'Amico TA Curr Opin Support Palliat Care; 2009 Jun; 3(2):107-11. PubMed ID: 19436210 [TBL] [Abstract][Full Text] [Related]
16. Dyspnea due to pulmonary hypertension and interstitial lung disease in scleroderma: room for improvement in diagnosis and management. Racz H; Mehta S J Rheumatol; 2006 Sep; 33(9):1723-5. PubMed ID: 16960934 [No Abstract] [Full Text] [Related]
17. Exercise limitation in interstitial lung disease - mechanisms, significance and therapeutic options. Holland AE Chron Respir Dis; 2010; 7(2):101-11. PubMed ID: 20056733 [TBL] [Abstract][Full Text] [Related]
18. Management of dyspnea in advanced pulmonary arterial hypertension. Sajkov D; Petrovsky N; Palange P Curr Opin Support Palliat Care; 2010 Jun; 4(2):76-84. PubMed ID: 20407377 [TBL] [Abstract][Full Text] [Related]
20. Advanced lung disease: quality of life and role of palliative care. Gilbert CR; Smith CM Mt Sinai J Med; 2009 Feb; 76(1):63-70. PubMed ID: 19170219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]